Varga J M, Kalchschmid G, Klein G F, Fritsch P
Department of Dermatology, University of Innsbruck, Austria.
Mol Immunol. 1991 Jun;28(6):641-54. doi: 10.1016/0161-5890(91)90133-5.
A recently developed solid-phase binding assay was used to investigate the specificity of ligand binding to a mouse monoclonal anti-dinitrophenyl IgE [IgE(aDNP)]. All DNP-amino acids, that were tested, inhibited the binding of radio-labeled IgE(aDNP) to DNP covalently attached to polystyrene microtiter plates; however, the concentration for 50% inhibition varied within four orders of magnitude, DNP-L-serine being the most, DNP-proline the least potent inhibitor. In addition to DNP analogues a large number (2074) of drugs and other compounds were tested for their ability to compete with DNP for the binding site of IgE(aDNP). At the concentrations used for screening 59% of the compounds had no significant inhibition; 19% inhibited the binding of IgE(aDNP) more than 50%. Several families of compounds (tetracyclines, polymyxines, phenotiazines, salicylates and quinones) of effective competitors were found. Within these families change in the functional groups attached to the "family stem" had major effects on the affinity of ligand binding. The occurrence frequencies of interactions of ligands with IgE(aDNP) is in good agreement with a semi-empirical model for multispecific antibody-ligand interactions.
最近开发的一种固相结合测定法被用于研究配体与小鼠单克隆抗二硝基苯基IgE[IgE(aDNP)]结合的特异性。所有测试的二硝基苯基氨基酸都能抑制放射性标记的IgE(aDNP)与共价连接在聚苯乙烯微量滴定板上的二硝基苯基的结合;然而,50%抑制率所需的浓度在四个数量级内变化,二硝基苯基-L-丝氨酸是最强的抑制剂,二硝基苯基-脯氨酸是最弱的抑制剂。除了二硝基苯基类似物外,还测试了大量(2074种)药物和其他化合物与二硝基苯基竞争IgE(aDNP)结合位点的能力。在用于筛选的浓度下,59%的化合物没有显著抑制作用;19%的化合物对IgE(aDNP)结合的抑制率超过50%。发现了几个有效竞争化合物家族(四环素类、多粘菌素类、吩噻嗪类、水杨酸盐类和醌类)。在这些家族中,连接在“家族主干”上的官能团的变化对配体结合亲和力有重大影响。配体与IgE(aDNP)相互作用的出现频率与多特异性抗体-配体相互作用的半经验模型高度一致。